NCT07154290
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07154290
Title A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Cancer Treatment Centers of America, Phoenix RECRUITING Goodyear Arizona 85338 United States Details
The City of Hope Orange County Lennar Foundation Cancer Center RECRUITING Irvine California 92618 United States Details
University of Illinois Chicago RECRUITING Chicago Illinois 60612 United States Details
Franciscan Health RECRUITING Munster Indiana 46321 United States Details
University of Maryland Greenebaum Comprehensive Cancer Center RECRUITING Baltimore Maryland 21201 United States Details
Washington University School of Medicine RECRUITING St Louis Missouri 63110 United States Details
University of Tennessee Medical Center RECRUITING Knoxville Tennessee 37920 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
University of Texas Medical Branch RECRUITING Galveston Texas 77555 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Baylor Scott & White Health RECRUITING Temple Texas 76508 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field